Navigation Links
Caliper Life Sciences Reports Second Quarter 2009 Results
Date:7/30/2009

2,490 3,114 4,979 Restructuring charges (credits), net 29 (27) 52 (20) Total costs and expenses 35,955 40,222 70,623 79,669 Operating loss (3,844) (6,191) (10,040) (16,351) Interest expense, net (179) (203) (391) (358) Other income (expense), net 66 (87) (117) 319 Provision for income taxes (96) (201) (150) (228) Net loss $(4,053) $(6,682) $(10,698) $(16,618) Net loss per share, basic and diluted $(0.08) $(0.14) $(0.22) $(0.35) Shares used in computing net loss per common share, basic and diluted 48,806 47,897 48,716 47,790 Reconciliation of GAAP to Non-GAAP Financial Measures Adjusted Basic Earnings per Share (see explanation of adjustments below) Three Months Ended Six Months Ended June 30, June 30, -------- -------- 2009 2008 2009 2008 ---- ---- ---- ---- GAAP EPS - Basic $(0.08) $(0.14) $(0.22) $(0.35) Adjustments: Acquisition related intangible amortization(1) 1,557 2,490 3,114 4,979 Restructuring and severance costs(2) 36 95 87 705 Total Adjustments $1,593 $2,585 $3,201 $5,684 Per share effect of adjustments 0.03 0.05 0.07 0.12 Adjusted earnings per share - Basic $(0.05) $(0.09) $(0.15) $(0.23) We use the term "adjusted earnings per share" or "adjusted EPS" to refer to GAAP earnings per share e
'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Caliper Life Sciences Second Quarter 2009 Financial Results Conference Call Notice
2. Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis
3. Caliper Life Sciences to Webcast Investor Session of Open House
4. Caliper Life Sciences Reports First Quarter 2009 Results
5. Caliper Life Sciences Announces Date and Location of its 2009 Annual Meeting of Stockholders
6. EPA Presents Initial Results from Caliper Life Sciences ToxCast Screening Effort
7. Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
8. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
9. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
10. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
11. Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Jan. 14, 2014 As pet owners drew up their lists ... them wrote: "Take better care of my furry companion." Nowadays there ... and top-brand carrying cases to take the little canine or feline ... feel compelled to buy some pricey toys at the pet store. ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo announced ... from the National Institutes of Health (NIH) to help ... effective treatments to patients on a faster timeline. Organovo ... Sciences (NCATS) and the National Eye Institute (NEI) to ...
(Date:1/14/2014)... , Jan. 14, 2014  RXi Pharmaceuticals Corporation ... developing and commercializing innovative therapies addressing major unmet ... it received the Notice of Allowance from the ... unique self-delivering RNAi compounds (sd-rxRNA®), for the treatment ...
(Date:1/14/2014)... USA, and Cardiff, UK (PRWEB) January 13, 2014 ... technology development leader with more than 20 years in ... for optics and photonics . Hainsey will serve as ... delighted to have Dr. Hainsey join SPIE as our ...
Breaking Biology Technology:New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2
... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a ... that BioSpecifics, President, Tom Wegman, will present at the upcoming ... 16, 2009, at 9:00 am ET at the Millennium Broadway ... , A live webcast of the presentation can ...
... ... experiments to demonstrate the power of nanotechnology based regenerative medicines. , ... (PRWEB) September 11, 2009 -- Long-time ... attempt to rejuvenate living animals with advanced nanotechnologies developed by his labs. The goal ...
... SUNRISE, Fla., Sept. 10 Bioheart, Inc., (OTC ... and biologics that help monitor, diagnose and treat heart failure ... President of R&D and Corporate development has been invited to ... Maryland, this month. , , Ms. Comella ...
Cached Biology Technology:Matthew Sarad to Reverse Aging and Cure Cancer 2Matthew Sarad to Reverse Aging and Cure Cancer 3Matthew Sarad to Reverse Aging and Cure Cancer 4Bioheart Inc. to Participate in the 2009 World Stem Cell Summit on September 23rd 2Bioheart Inc. to Participate in the 2009 World Stem Cell Summit on September 23rd 3
(Date:4/17/2014)... A Kansas State University engineer has developed ... remotely detects improvised explosive devices. The same technique ... Dunn, the Steven M. and Kay L. Theede ... and nuclear engineering, and his research team have ... underground or in car trunks. The distance detection ...
(Date:4/17/2014)... parasites and pathogens that devastate honeybees in Europe, Asia ... but do not appear to be impacting native honeybee ... of researchers., The invasive pests include including Nosema ... African honeybees appear to be resilient to these invasive ... to control pests in Europe, Asia and the United ...
(Date:4/17/2014)... Researchers reporting in the Cell Press journal Current ... insects with rather novel sex lives. The Brazilian insects, ... genus Neotrogla , are the first example of ... reversal has been identified in several different animals, ... intromittent organ is also reversed," says Kazunori Yoshizawa from ...
Breaking Biology News(10 mins):Patented research remotely detects nitrogen-rich explosives 2East African honeybees are safe from invasive pests… for now 2East African honeybees are safe from invasive pests… for now 3In sex-reversed cave insects, females have the penises 2
... USA/BEIJING, CHINA -- The global fight against the tuberculosis ... China National Biotec Group (CNBG) announce that they have ... vaccines. The agreement between the leading non-profit developer of ... China signals a commitment by both to engage and ...
... UC Santa Barbara geochemist David Valentine and colleagues published a ... almost all of the deepwater methane plumes following the Deepwater ... they asked, could almost all of the lethal gas emitted ... new study published in the Proceedings of the National ...
... and the political instability in the region have kept researchers ... But Hyongki Lee, a University of Houston civil engineering researcher, ... mysterious region _ studying it from space. , Lee won,t ... plans to use unanalyzed satellite images to survey the basin,s ...
Cached Biology News:Aeras and CNBG sign agreement on tuberculosis vaccine R&D 2UCSB scientists say topography played key role in Deepwater Horizon disaster 2UCSB scientists say topography played key role in Deepwater Horizon disaster 3UCSB scientists say topography played key role in Deepwater Horizon disaster 4University of Houston wins NASA grant to study Congo River Basin 2
Mouse monoclonal antibody raised against a partial recombinant ENTPD5. NCBI Entrez Gene ID = ENTPD5...
Mouse monoclonal antibody raised against a partial recombinant CHD8. NCBI Entrez Gene ID = CHD8...
Mouse polyclonal antibody raised against a partial recombinant SYT4. NCBI Entrez Gene ID = 6860...
Mouse monoclonal antibody raised against a full length recombinant SNAPC5. NCBI Entrez Gene ID = SNAPC5...
Biology Products: